Free Trial

Humana (HUM) Competitors

$358.12
+10.74 (+3.09%)
(As of 05/31/2024 ET)

HUM vs. ELV, CI, CNC, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE

Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Elevance Health (ELV), The Cigna Group (CI), Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.

Humana vs.

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, community ranking, earnings, valuation and risk.

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.82%. Humana's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
Humana 1.82%17.76%5.63%

In the previous week, Elevance Health had 8 more articles in the media than Humana. MarketBeat recorded 24 mentions for Elevance Health and 16 mentions for Humana. Humana's average media sentiment score of 0.88 beat Elevance Health's score of 0.82 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
9 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.73$5.99B$26.4620.35
Humana$106.37B0.41$2.49B$16.0622.30

Elevance Health currently has a consensus target price of $598.23, indicating a potential upside of 11.10%. Humana has a consensus target price of $423.63, indicating a potential upside of 18.29%. Given Elevance Health's higher possible upside, analysts plainly believe Humana is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
3.00
Humana
0 Sell rating(s)
12 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.43

Elevance Health has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500.

Humana received 49 more outperform votes than Elevance Health when rated by MarketBeat users. However, 66.75% of users gave Elevance Health an outperform vote while only 64.01% of users gave Humana an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
835
66.75%
Underperform Votes
416
33.25%
HumanaOutperform Votes
884
64.01%
Underperform Votes
497
35.99%

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.0%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Humana pays out 22.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 13 consecutive years and Humana has raised its dividend for 7 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by insiders. Comparatively, 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Elevance Health beats Humana on 17 of the 22 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$43.15B$65.58B$5.13B$17.79B
Dividend Yield1.02%1.39%2.75%3.55%
P/E Ratio22.3022.09167.1725.81
Price / Sales0.410.562,418.7811.40
Price / Cash10.149.7635.3018.95
Price / Book2.674.065.535.90
Net Income$2.49B$3.04B$106.01M$976.46M
7 Day Performance2.53%1.63%1.14%0.62%
1 Month Performance13.97%13.97%1.43%4.79%
1 Year Performance-30.48%24.07%4.07%24.00%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.7689 of 5 stars
$519.19
-0.4%
$587.42
+13.1%
+15.9%$120.67B$171.34B19.62104,900Analyst Upgrade
Short Interest ↓
News Coverage
Gap Up
CI
The Cigna Group
4.7418 of 5 stars
$333.21
+0.2%
$366.14
+9.9%
+36.0%$94.66B$204.15B27.3672,500Analyst Forecast
CNC
Centene
4.8155 of 5 stars
$72.72
-2.6%
$85.23
+17.2%
+10.2%$38.81B$154.00B14.4667,700Analyst Forecast
Options Volume
News Coverage
MOH
Molina Healthcare
4.9789 of 5 stars
$324.09
-2.4%
$404.90
+24.9%
+11.2%$18.99B$34.07B17.58123,123Analyst Forecast
News Coverage
UNH
UnitedHealth Group
4.9415 of 5 stars
$503.68
-0.9%
$570.05
+13.2%
+0.4%$463.58B$371.62B30.79440,000Analyst Forecast
News Coverage
OSCR
Oscar Health
2.6216 of 5 stars
$20.43
-0.6%
$17.67
-13.5%
+169.0%$4.85B$5.86B-51.072,400Analyst Forecast
Short Interest ↓
News Coverage
ALHC
Alignment Healthcare
2.9871 of 5 stars
$7.41
+3.5%
$8.69
+17.3%
+33.6%$1.42B$1.82B-8.821,536Analyst Upgrade
Short Interest ↓
News Coverage
Positive News
TRUP
Trupanion
1.7456 of 5 stars
$27.94
-3.5%
$32.80
+17.4%
+32.6%$1.17B$1.16B-43.661,142Positive News
CLOV
Clover Health Investments
1.82 of 5 stars
$1.01
+1.0%
$1.50
+48.5%
+29.7%$501.40M$2.03B-2.97552Short Interest ↓
NEUE
NeueHealth
1.5187 of 5 stars
$5.98
+0.5%
$8.00
+33.8%
N/A$49.18M$1.11B-0.051,252Short Interest ↑
Negative News
Gap Down

Related Companies and Tools

This page (NYSE:HUM) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners